Yesterday we touched on the advances of robot radiosurgery techniques and the increasing role they play in cancer treatment worldwide. Embodied in solutions like Intuitive Surgical's da Vinci surgical system, robot assisted surgery is becoming more commonplace in the operating theater.
Device Technologies Australia, a major supplier of leading edge medical equipment and consumables to hospitals and healthcare professionals throughout Australia and New Zealand is touting a revolutionary robotic system designed safely, accurately and cost-effectively automate the sterile preparation of Oncology I.V. Admixtures.
Health Robotics is a supplier of life-critical intra-venous medication preparation, compounding, and dispensing robots, providing healthcare facilities worldwide with robotics technology and software automation solutions. The company's CytoCare Robot automatically compounds and prepares ready-to-administer hazardous intravenous (IV) solutions.
The two companies announced an exclusive five-year strategic partnership whereby Device Technologies will distribute Health Robotics' CytoCare solution. Among the benefits touted by this technology is the ability to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, increase throughput, reduce waste, and contain costs.